Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Gynecologic Oncology

Breast Cancer

Multiple Myeloma

Lung Cancer

Immuno-Oncology News

Gastrointestinal Cancer

Gynecologic Oncology

Matulonis Highlights Niraparib, Immunotherapy Data in Ovarian Cancer

Ursula A. Matulonis, MD, highlights the activity and tolerability of niraparib and discusses other recent data in ovarian cancer.
Read More >>

Patient-Experienced Toxicity Is a Biomarker Worth Considering

Novel Combination Shows Early Efficacy in Ovarian Cancer

Tumor Treating Fields Show Promise in Ovarian Cancer

Expert Discusses Treatment, Histogenesis of Gynecologic Cancers

Novel Frontline Regimens Are Emerging for Advanced Ovarian Cancer

View More Stories >>

View Conference Coverage

2018 International Lung Cancer Congress

2018 Pan Pacific Lymphoma Conference

2nd Annual Live Medical Crossfire® : Hematologic Malignancies

State of the Science Summit on A Summer of Progress: Updates from ASCO 2018

2018 State of the Science Summit on Breast Cancer

Dr. Hardesty on Bevacizumab/PARP Inhibitor Combination in Ovarian Cancer

Dr. Matulonis Discusses QoL Data from GOG-258 in Endometrial Cancer

Dr. Turner on Important Steps for Genomic Profiling in Gynecologic Malignancies

Dr. Konecny on Response to PARP Inhibitors in Ovarian Cancer

Dr. Tewari on Immunotherapeutic Strategies in Cervical Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

Neoadjuvant Therapy in Advanced Ovarian Cancer

Surgical Controversies in Advanced Ovarian Cancer

Molecular Testing in Ovarian Cancer

Chemotherapy in Early-Stage Ovarian Cancer

Managing Ovarian Cancer Patients in the Future

Therapy Selection in BRCA-Mutated Ovarian Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

The Future Role of PARP Inhibition in Ovarian Cancer

Combinations With PARP Inhibitors for Ovarian Cancer

Ovarian Cancer: Selecting an Appropriate PARP Inhibitor

Ovarian Cancer: Treating Through Multiple Progressions

Ovarian Cancer: Comparisons Between PARP Inhibitors

Ovarian Cancer: Deciding Among PARP Inhibitors

Ovarian Cancer: Optimizing Treatment With Niraparib

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

Emerging Concepts-Advanced Ovarian, Fallopian, Peritoneal, and Cervical Cancers

This discussion, led by James Tate Thigpen, MD, features the most recent information pertaining to treatment of gynecologic malignancies. The expert panel, Robert L. Coleman, MD, FACOG, FACS; Thomas Herzog, MD; Bradley J. Monk, MD, FACOG, FACS; and Angeles Alvarez Secord, MD, review the research and how to apply it in practice.View Now

Challenges for the Future of Gynecologic Cancers

Panelists provide their perspectives on the key challenges facing the future of ovarian and cervical cancer treatment.View Now

Featured Video

Immunotherapy in the Treatment of Follicular Lymphoma

Ian W. Flinn, MD, PhD; Grzegorz S. Nowakowski, MD; Loretta J. Nastoupil, MD; and Anas Younes, MD, reflect on the value of immunotherapy, immunotherapy combination strategies, and understanding the tumor microenvironment in treating follicular lymphoma.View now

FDA Approval in CTCL, Breakthrough Therapy Designation in CRC, and More